We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $111M
1-Year Est. Return 74.4%
This Fund
S&P 500
This Quarter Est. Return
-11.53%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$361M
AUM Growth
+$175M
Cap. Flow
-$2.52M
Cap. Flow %
-0.7%
Top 10 Hldgs %
90.77%
Holding
111
New
18
Increased
19
Reduced
27
Closed
38

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$5.25M
2
TRAW icon
Traws Pharma
TRAW
+$3.96M
3
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
+$1.9M
4
BPTH
Bio-Path Holdings Inc
BPTH
+$1.16M
5
TOPS icon
TOP Ships
TOPS
+$1.13M

Top Sells

Rank Stock Value
1
TEUM
Pareteum Corporation
TEUM
+$2.9M
2
RDGT
Ridgetech Inc
RDGT
+$1.59M
3
CRMD icon
CorMedix
CRMD
+$1.59M
4
ARCT icon
Arcturus Therapeutics
ARCT
+$1.28M
5
ATNM icon
Actinium Pharmaceuticals
ATNM
+$1.27M

Sector Composition

Rank Sector Weight
1 Miscellaneous 94.27%
2 Healthcare 5.45%
3 Industrials 0.18%
4 Technology 0.07%
5 Consumer Discretionary 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OGEN icon
51
Oragenics
OGEN
$2.2M
$184K 0.05%
195
-149
-43% -$133K
BLIN icon
52
Bridgeline Digital
BLIN
$11M
$169K 0.05%
110,000
– –
VKTX icon
53
CALL
Viking Therapeutics
VKTX
$3.49B
$160K 0.04%
200
– –
HURA
54
TuHURA Biosciences
HURA
$129M
$153K 0.04%
701
+157
+29% +$169K
GNPX icon
55
Genprex
GNPX
$2.71M
$142K 0.04%
10
-3
-23% -$54.6K
LPCN icon
56
Lipocine
LPCN
$18.1M
$142K 0.04%
+21,629
New +$554K
IMNN icon
57
Imunon
IMNN
$7.86M
$117K 0.03%
350
-448
-56% -$136K
SHIPZ
58
DELISTED
Seanergy Maritime Holdings Corp Class B Warrant
SHIPZ
$100K 0.03%
907,999
-9,338
-1% -$1.66K
NTBL
59
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$96K 0.03%
2,294
-1,125
-33% -$48.6K
QCLS
60
Q/C Technologies Inc
QCLS
$3.61M
$93K 0.03%
+5
New +$212K
CSCI
61
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$93K 0.03%
1,020
+299
+41% +$27.9K
MDGSW
62
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$93K 0.03%
1,008,444
– –
SRNE
63
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$92K 0.03%
+27,178
New +$64.8K
ALT icon
64
Altimmune
ALT
$628M
$85K 0.02%
44,855
+3,097
+7% +$5.72K
SPHS
65
DELISTED
Sophiris Bio, Inc.
SPHS
$68K 0.02%
+42,378
New +$19.2K
TENX icon
66
Tenax Therapeutics
TENX
$68.5M
$61K 0.02%
+27
New +$52.6K
IMNN icon
67
PUT
Imunon
IMNN
$7.86M
$31K 0.01%
1
– –
RBZ
68
DELISTED
Reebonz Holding Limited Ordinary Shares
RBZ
$29K 0.01%
+25,000
New +$30.1K
SHIP icon
69
Seanergy Maritime Holdings
SHIP
$401M
$27K 0.01%
312
-7,251
-96% -$639K
SNES icon
70
SenesTech
SNES
$4.67M
$27K 0.01%
1
– –
DMK
71
PUT
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$8K ﹤0.01%
2
– –
CHGA
72
Change Agents Corp
CHGA
$2.09M
– –
-66
Closed -$369K
ALT icon
73
PUT
Altimmune
ALT
$628M
– –
-134
Closed -$26K
ARCT icon
74
Arcturus Therapeutics
ARCT
$450M
– –
-124,843
Closed -$1.28M
CARM
75
PUT
DELISTED
Carisma Therapeutics
CARM
– –
-18
Closed -$43K
1 2
3
4 5

Similar funds

IWA
Independent Wealth Advisors Cary, North Carolina $111M AUM
BFA
Ballast Financial Advisors West Chester, Pennsylvania $110M AUM
WPWM
Western Pacific Wealth Management Lake Forest, Illinois $111M AUM 26.64% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
ZS
Zenith Solutions Philadelphia, Pennsylvania $110M AUM
KC
Karras Company Roy, Utah $110M AUM
FI
FinArc Investments Norwood, Massachusetts $110M AUM
CIM
Catalyst Investment Management Windham, New Hampshire $110M AUM

Sabby Management's Q4 2019 Portfolio in Review

As of Q4 2019, Sabby Management held 111 positions worth $361M, up 94% from $186M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Sabby Management's Q4 2019 filing shows 18 new, 19 increased, 27 reduced and 38 closed positions. Its largest new stake was SPDR Gold Trust: 37,550 shares worth $5.37M. The largest sale was Pareteum Corporation, an estimated $2.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 82% a quarter earlier, followed by Healthcare and Industrials.

  • Sabby Management's largest Q4 2019 buy was SPDR Gold Trust: 37,550 shares worth $5.37M.
  • Sabby Management added most to Traws Pharma in Q4 2019, an estimated $3.96M increase.
  • Sabby Management's biggest Q4 2019 reduction was Actinium Pharmaceuticals, cutting an estimated $1.27M.
  • Sabby Management fully exited Pareteum Corporation in Q4 2019, selling an estimated $2.9M.
  • Sabby Management's ten largest holdings make up 91% of its $361M portfolio in Q4 2019.
  • Sabby Management opened 18 new positions and closed 38 in Q4 2019.
  • Sabby Management's portfolio value rose 94% quarter-over-quarter to $361M.

Based on Sabby Management's 13F filing for Q4 2019, filed 14 Feb 2020.